The Role of Nerve Blocks in Hip Arthroscopy

• Status: Withdrawn
• Trial end date: 2020-02-07
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this study is to determine whether QL blocks reduce opioid consumption following arthroscopic hip surgery by decreasing postoperative pain. Considering the current opioid epidemic, the responsibility of physicians to help prevent addiction, and the increasing prevalence of arthroscopic hip surgeries, this study holds a tremendous potential benefit for future patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Columbia University
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Patients scheduled to receive unilateral arthroscopy hip surgery at Columbia University Medical Center with Dr. Lynch.

Exclusion Criteria:

• Patients scheduled to receive bilaterally or staged hip arthroscopy.

• Patients unwilling to participate in the research.

• History of chronic opioid use.

• Contraindication or allergy to study medications, such as QL block.